We analyzed the RNA-seq and tumor progression data from “Liver Hepatocellular Carcinoma (TCGA, provisional)” at cBioPortal [18–19] and found that high expression of BRF1 predicts a poor overall survival (20.6 versus 53.3 months, P=0.032, Supplementary Figure S1). This evidence concerns the gene BRF1 and neoplasm.